While technological advances such as continuous glucose monitoring devices and/or insulin pumps have improved quality of life for some patients (150, 151), the use of external insulin carries a dual burden, being both costly and entailing significant risks due to potential complications like severe hypoglycemia or hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.